Phase IV Cluster-Randomized Trial Tests Machine Learning AKI Risk Prediction in Perioperative Care — What Clinicians Need to Know

References

1. 1.University of California, San Francisco. (2024). Prediction of Acute Kidney Injury (AKI) After Surgery: A Pragmatic Three-Arm Cluster-Randomized Trial. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07604662
2. 2.Kellum, J. A., Romagnani, P., Ashuntantang, G., Ronco, C., Zarbock, A., & Anders, H. J. (2021). Acute kidney injury. Nature Reviews Disease Primers, 7(1), 52. https://doi.org/10.1038/s41572-021-00284-z
3. 3.Bihorac, A., Ozrazgat-Baslanti, T., Ebadi, A., Motaei, A., Madkour, M., Pardalos, P. M., Lipori, G., Hogan, W. R., Efron, P. A., Moore, F., Moldawer, L. L., Wang, D. Z., Hobson, C. E., Rashidi, P., & Upchurch Jr, G. R. (2019). MySurgeryRisk: development and validation of a machine-learning risk algorithm for major complications and death after surgery. Annals of Surgery, 269(4), 652-662. https://doi.org/10.1097/SLA.0000000000002706
4. 4.Khwaja, A. (2012). KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 120(4), c179-c184. https://doi.org/10.1159/000339789
5. 5.Ford, I., & Norrie, J. (2016). Pragmatic trials. New England Journal of Medicine, 375(5), 454-463. https://doi.org/10.1056/NEJMra1510059
6. 6.Grams, M. E., Sang, Y., Coresh, J., Ballew, S., Matsushita, K., Molnar, M. Z., Szabo, Z., Mehta, R. L., & CKD Prognosis Consortium. (2016). Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. American Journal of Kidney Diseases, 68(6), 872-880. https://doi.org/10.1053/j.ajkd.2015.07.022
7. 7.Coca, S. G., Singanamala, S., & Parikh, C. R. (2012). Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney International, 81(5), 442-448. https://doi.org/10.1038/ki.2011.379
8. 8.Meersch, M., Schmidt, C., Hoffmeier, A., Van Aken, H., Wempe, C., Gerss, J., & Zarbock, A. (2017). Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers. Journal of the American College of Cardiology, 69(3), 236-247. https://doi.org/10.1016/j.jacc.2016.10.019